<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04970641</url>
  </required_header>
  <id_info>
    <org_study_id>21-003878</org_study_id>
    <nct_id>NCT04970641</nct_id>
  </id_info>
  <brief_title>Three Good Things (3GT) - Intervention for Transitional Care Patients</brief_title>
  <official_title>Three Good Things (3GT) - Intervention for Transitional Care Patients at the Mayo Clinic Bloomer Critical Access Hospital</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Mayo Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Mayo Clinic</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Researchers are doing this research study to learn how the Three Good Things (3GT) Positive&#xD;
      Psychology journaling activity affects symptoms of stress, depression, resilience, and&#xD;
      happiness.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The purpose of this study is to measure, rank and categorize the subject sample of&#xD;
      depression, stress, resilience and happiness scores using quantitative surveys. This research&#xD;
      aims to learn how a Three Good Things (3GT) journaling activity affects a subject's symptoms&#xD;
      of stress, depression, resilience and happiness. The data will allow the project team to gain&#xD;
      an in-depth understanding of the impact of the use of resilience strategies from a&#xD;
      hospitalized patient's perspective. The project aims to review if there is a correlation&#xD;
      between stress, depression, resiliency, and happiness scores to the use of Positive&#xD;
      Psychology.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 30, 2021</start_date>
  <completion_date type="Anticipated">March 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Perceived Stress</measure>
    <time_frame>Baseline, 6 weeks</time_frame>
    <description>Change in subject perceived stress measured using the self-reported perceived stress scale (PSS). A 10-item questionnaire assessing individuals' appraisal of stress using a scale of 0=never, 4=very often.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective Depression</measure>
    <time_frame>Baseline, 6 weeks</time_frame>
    <description>Change in subject depression measured using the Center for Epidemiologic Studies Depression Scale-Revised (CESD-R-10).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Happiness</measure>
    <time_frame>Baseline, 6 weeks</time_frame>
    <description>Change in subject happiness measured using the self-reported subjective happiness scale (SHS). A 4-item scale of global subjective happiness. Two items ask respondents to characterize themselves using both absolute ratings and ratings relative to peers, whereas the other two items offer brief descriptions of happy and unhappy individuals and ask respondents the extent to which each characterization describes them.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Resilience</measure>
    <time_frame>Baseline, 6 weeks</time_frame>
    <description>Change in subject resiliency scores measured by the Connor-Davidson Resilience Scale (CD-RISC 2)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Positive Thinking</condition>
  <condition>Psychology, Positive</condition>
  <condition>Resilience, Psychological</condition>
  <arm_group>
    <arm_group_label>3GT journaling group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will participate in the Three Good Things (3GT) Positive Psychology journaling activity daily for six weeks.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-journaling group</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Subjects will not participate in the evening journal activity.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Three Good Things (3GT) Positive Psychology journaling activity</intervention_name>
    <description>Evening journaling activity each day to reflect on three good things that the subject has noticed about their day's events.</description>
    <arm_group_label>3GT journaling group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Individuals â‰¥ 18 years of age.&#xD;
&#xD;
          -  Current inpatient at the Mayo Clinic Health System Bloomer Hospital, Bloomer,&#xD;
             Wisconsin (a Swing Bed Hospital as defined by the Center for Medicare and Medicaid&#xD;
             Services (CMS)).&#xD;
&#xD;
          -  Able to speak English.&#xD;
&#xD;
          -  Able to answer questionnaires.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Individuals &lt; 18 years of age.&#xD;
&#xD;
          -  Patient unwilling or unable to provide consent to participate in this research study.&#xD;
&#xD;
          -  Patient under guardianship.&#xD;
&#xD;
          -  As determined through self-report, patient in active psychosis, active suicidal&#xD;
             ideation, active substance abuse meeting criteria for substance use disorders except&#xD;
             for nicotine (the exception is patients with a history of substance abuse that have&#xD;
             been in remission for at least one full year).&#xD;
&#xD;
          -  Patient diagnosed with obsessive-compulsive disorder, active panic disorder with&#xD;
             agoraphobia or other phobic disorder, active Post Traumatic Stress Disorder, or active&#xD;
             severe personality disorders.&#xD;
&#xD;
          -  Patient with previous participation in this study.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lori M Miller, MAOM, RN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mayo Clinic</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Mayo Clinic Health System Bloomer Hospital</name>
      <address>
        <city>Bloomer</city>
        <state>Wisconsin</state>
        <zip>54724</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Lori M Miller, RN, MAOM</last_name>
      <phone>715-568-6543</phone>
      <email>miller.lori4@mayo.edu</email>
    </contact>
    <investigator>
      <last_name>Lori M Miller, MAOM, RN</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sherry Chesak, PhD, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://www.mayo.edu/research/clinical-trials</url>
    <description>Mayo Clinic Clinical Trials</description>
  </link>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>July 19, 2021</study_first_submitted>
  <study_first_submitted_qc>July 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 21, 2021</study_first_posted>
  <last_update_submitted>September 30, 2021</last_update_submitted>
  <last_update_submitted_qc>September 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Mayo Clinic</investigator_affiliation>
    <investigator_full_name>Lori M. Miller</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>There is no plan to share individual participant data to other researchers.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

